The purpose of this clinical trial is to evaluate the safety of an investigational drug for diabetes. This clinical trial will measure heart and kidney health in adult patients with diabetes and kidney disease who have an elevated risk of cardiovascular disease. The investigational drug used in this trial will be compared against a placebo.
Patients who qualify to participate in this clinical trial may receive trial-related medication and medical care at no cost.
Diabetes is one of the fastest growing conditions in the U.S. According to the American Diabetes Association, more than 30 million Americans (over 9% of the population) have the disease, with an additional 1.4 million diagnoses made each year.1
Those living with diabetes can be at an elevated risk for heart disease. Cardiovascular disease is the underlying cause of nearly 801,000 deaths in the U.S. each year—approximately one out of every three deaths. About 2,200 Americans die of cardiovascular disease each day, an average of one death every 40 seconds.2
Adults with diabetes are two to four times more likely to die from heart disease than adults without diabetes.3 Therefore, the development of medications that treat diabetes while decreasing the risk of death from cardiovascular disease and heart failure and/or progression of kidney disease is urgent.
People who participate in clinical trials aid others with the same condition by helping the scientific community find new treatment options for diseases such as Type 2 Diabetes.
1 Statistics About Diabetes. Diabetes.org. Updated July 19, 2017. Accessed November 15, 2017.
2 Heart Disease, Stroke and Research Statistics At-a-Glance. Heart.org. Published December 16, 2015. Accessed November 15, 2017.
3 Cardiovascular Disease & Diabetes. Heart.org. Updated April 14, 2017. Accessed November 15, 2017.